We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.84B
AUM Growth
+$1.62B
(+22%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
19.13%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
656
New
169
Increased
202
Reduced
101
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rithm Capital
RITM
|
+$78.4M |
| 2 |
Infosys
INFY
|
+$65M |
| 3 |
F5
FFIV
|
+$64.6M |
| 4 |
Western Digital
WDC
|
+$62.1M |
| 5 |
Cigna
CI
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$69.1M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$68.2M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$57.6M |
| 4 |
Medtronic
MDT
|
+$51.8M |
| 5 |
DRC
DRESSER-RAND GROUP INC
DRC
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.28% |
| 2 | Healthcare | 13.44% |
| 3 | Technology | 12.36% |
| 4 | Financials | 10.47% |
| 5 | Energy | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
El Pollo Loco
LOCO
$462M
| $1.06M | 0.01% |
+51,356
| New | +$1.25M |
|
402
Cerus
CERS
$474M
| $1.05M | 0.01% |
203,191
-96,709
| -32% | -$458K |
|
|
SCHW
403
Charles Schwab
SCHW
$187B
| $1.05M | 0.01% |
+32,243
| New | +$1.02M |
|
|
ASXC
404
DELISTED
Asensus Surgical, Inc.
ASXC
| $1.05M | 0.01% |
+26,923
| New | +$1.24M |
|
|
PARN
405
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
| $1.03M | 0.01% |
207,959
+52,558
| +34% | +$232K |
|
406
Identive
INVE
$61.9M
| $969K | 0.01% |
164,568
+2,664
| +2% | +$20.9K |
|
|
BIOA
407
DELISTED
BioAmber Inc.
BIOA
| $964K | 0.01% |
+112,043
| New | +$1.02M |
|
408
Kennametal
KMT
$2.52B
| $946K | 0.01% |
+27,712
| New | +$993K |
|
409
Box
BOX
$4.6B
| $932K | 0.01% |
+50,000
| New | +$878K |
|
|
BIOA
410
CALL
DELISTED
BioAmber Inc.
BIOA
| $932K | 0.01% |
108,391
+1,755
| +2% | +$16.1K |
|
|
ARGS
411
DELISTED
Argos Therapeutics, Inc.
ARGS
| $908K | 0.01% |
6,629
-1,223
| -16% | -$195K |
|
|
AVOL
412
DELISTED
AVOLON HLDGS LTD SHS (CYM)
AVOL
| $902K | 0.01% |
39,294
-22,047
| -36% | -$503K |
|
|
TBCH
413
Turtle Beach Corp
TBCH
$277M
| $871K | 0.01% |
95,477
+1,546
| +2% | +$13.4K |
|
414
Glaukos
GKOS
$10.6B
| $869K | 0.01% |
+30,000
| New | +$872K |
|
|
AVDL
415
DELISTED
Avadel Pharmaceuticals
AVDL
| $868K | 0.01% |
40,973
-596,477
| -94% | -$10.7M |
|
416
Shopify
SHOP
$195B
| $849K | 0.01% |
+250,000
| New | +$781K |
|
|
OPWR
417
DELISTED
OPOWER INC COM STK (DE)
OPWR
| $810K | 0.01% |
70,384
-153,616
| -69% | -$1.71M |
|
418
Olin
OLN
$2.12B
| $784K | 0.01% |
29,073
-607,822
| -95% | -$18M |
|
|
AVGR
419
DELISTED
Avinger, Inc. Common Stock
AVGR
| $780K | 0.01% |
+1
| New | +$1.41M |
|
420
Tenet Healthcare
THC
$21.1B
| $767K | 0.01% |
+13,249
| New | +$677K |
|
421
Packaging Corp of America
PKG
$22.8B
| $766K | 0.01% |
12,250
-324,747
| -96% | -$22.9M |
|
|
BLPH
422
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $759K | 0.01% |
6,379
+104
| +2% | +$14.1K |
|
423
Compass Minerals
CMP
$1.15B
| $750K | 0.01% |
9,127
-275,236
| -97% | -$24.2M |
|
|
AXAS
424
DELISTED
Abraxas Petroleum Corp
AXAS
| $750K | 0.01% |
12,706
-2,618
| -17% | -$171K |
|
|
WINT
425
DELISTED
Windtree Therapeutics Inc
WINT
| $749K | 0.01% |
78,722
-20,670
| -21% | -$290K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2015 Portfolio in Review
As of Q2 2015, Alyeska Investment Group held 656 positions worth $8.84B, up 22% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alyeska Investment Group deployed $1.69B of net new capital in Q2 2015, opening 169 new positions and adding to 202 existing holdings. Its largest new stake was Infosys: 8,002,538 shares worth $63.4M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Ciena, an estimated $33.5M trimmed.
- Alyeska Investment Group's largest Q2 2015 buy was Infosys: 8,002,538 shares worth $63.4M.
- Alyeska Investment Group added most to Rithm Capital in Q2 2015, an estimated $78.4M increase.
- Alyeska Investment Group's biggest Q2 2015 reduction was Ciena, cutting an estimated $33.5M.
- Alyeska Investment Group fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $69.1M.
- Alyeska Investment Group's ten largest holdings make up 18% of its $8.84B portfolio in Q2 2015.
- Alyeska Investment Group opened 169 new positions and closed 175 in Q2 2015.
- Alyeska Investment Group's portfolio value rose 22% quarter-over-quarter to $8.84B.
Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.